COPD News

Variations in chronic respiratory disease mortality appeared to be associated with U.S. county-level sociodemographic vulnerabilities, researchers reported in Annals of the American Thoracic Society.

Patients with severe heterogeneous emphysema treated with a support expiration valve system had a sustained clinically significant benefit in health-related quality of life at 24 months in the EMPROVE trial.

Pulmonary rehabilitation led to significant benefits among individuals with COPD regardless of inhaled triple therapy treatment, researchers reported in Respiratory Medicine.

Web-based self-management support led to short-term increases in physical activity among adults with COPD, researchers reported at the European Respiratory Society International Congress.

Icenticaftor did not yield a dose response for trough FEV1 at 12 weeks, but treatment was associated with improved symptoms at 24 weeks in patients with COPD and chronic bronchitis on inhaled triple therapy, researchers reported.

Personalized point-of-care eosinophil-guided oral prednisolone therapy in primary care was safe and did not worsen outcomes in individuals with COPD exacerbations, researchers reported at the European Respiratory Society International Congress.

Inhaled dual bronchodilator therapy did not decrease respiratory symptoms among individuals who were current or former smokers and had respiratory symptoms but preserved lung function without COPD, according to results of the RETHINC study.

The loss of small, distal pulmonary arteries was associated with progression of CT-derived bronchiectasis, especially among smokers with COPD, according to results published in Respiratory Medicine Journal.

Higher intake of dietary flavonoids may mitigate some risk for COPD in current and former smokers, according to a study published in European Respiratory Journal.

Population density, pedestrian street length and slope and nitrogen dioxide exposure were all associated with physical activity levels and exercise capacity of patients with COPD living in highly populated areas, researchers reported.